(Q30380300)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19722894%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

review article

1 reference

title

Prospects for developing an effective particle-mediated DNA vaccine against influenza (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19722894%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19722894%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Deborah H Fuller

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19722894%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Hansi J Dean

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19722894%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

1 September 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19722894%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Vaccines

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19722894%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19722894%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19722894%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

1205-1220

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19722894%20AND%20SRC:MED&resulttype=core&format=json

H9N2 influenza viruses possessing H5N1-like internal genomes continue to circulate in poultry in southeastern China

6 February 2020

cites work

1 reference

Emergence of a novel swine-origin influenza A (H1N1) virus in humans

21 January 2018

1 reference

Implications of pandemic influenza for bioterrorism response.

21 January 2018

1 reference

Emerging infections: pandemic influenza

21 January 2018

1 reference

Influenza pandemic preparedness plan for the United States

21 January 2018

1 reference

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine

21 January 2018

1 reference

Community-acquired influenza C virus infection in children

21 January 2018

1 reference

Influenza-associated hospitalizations in the United States

21 January 2018

1 reference

Mortality associated with influenza and respiratory syncytial virus in the United States

21 January 2018

1 reference

Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase.

21 January 2018

1 reference

Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs

21 January 2018

1 reference

Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus

21 January 2018

1 reference

Further protection against antigenic drift of influenza virus in a ferret model by DNA vaccination

21 January 2018

1 reference

Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines.

21 January 2018

1 reference

Antibody responses to DNA vaccination of horses using the influenza virus hemagglutinin gene

21 January 2018

1 reference

DNA immunization for influenza virus: studies using hemagglutinin- and nucleoprotein-expressing DNAs

21 January 2018

1 reference

Protection against influenza B virus infection by immunization with DNA vaccines.

21 January 2018

1 reference

C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge

21 January 2018

1 reference

Electroporation of synthetic DNA antigens offers protection in nonhuman primates challenged with highly pathogenic avian influenza virus

21 January 2018

1 reference

Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens

21 January 2018

1 reference

Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine

21 January 2018

1 reference

Cell-mediated protection in influenza infection.

21 January 2018

1 reference

CD4+ T-cell memory: generation and multi-faceted roles for CD4+ T cells in protective immunity to influenza.

21 January 2018

1 reference

Functional diversity of helper T lymphocytes

21 January 2018

1 reference

Vaccination with DNA encoding internal proteins of influenza virus does not require CD8(+) cytotoxic T lymphocytes: either CD4(+) or CD8(+) T cells can promote survival and recovery after challenge

21 January 2018

1 reference

DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice.

21 January 2018

1 reference

Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene

21 January 2018

1 reference

Protection against influenza virus challenge by topical application of influenza DNA vaccine

21 January 2018

1 reference

In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment

21 January 2018

1 reference

Targeting the skin for genetic immunization

21 January 2018

1 reference

Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases

21 January 2018

1 reference

Powder and particle-mediated approaches for delivery of DNA and protein vaccines into the epidermis

21 January 2018

1 reference

Particle-mediated DNA vaccine delivery to the skin

21 January 2018

1 reference

Particle-mediated nucleic acid immunization

21 January 2018

1 reference

DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial

21 January 2018

1 reference

NY-ESO-1 DNA vaccine induces T-cell responses that are suppressed by regulatory T cells.

21 January 2018

1 reference

Vaccination strategies for mucosal immune responses

21 January 2018

1 reference

Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells

21 January 2018

1 reference

The induction of systemic and mucosal immune responses to antigen-adjuvant compositions administered into the skin: alterations in the migratory properties of dendritic cells appears to be important for stimulating mucosal immunity

21 January 2018

1 reference

Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccine

21 January 2018

1 reference

A multi-valent vaccine approach that elicits broad immunity within an influenza subtype.

21 January 2018

1 reference

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations

21 January 2018

1 reference

Protection of mice from H5N1 influenza challenge by prophylactic DNA vaccination using particle mediated epidermal delivery.

21 January 2018

1 reference

The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods

21 January 2018

1 reference

Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8(+) cytotoxic T lymphocyte responses induced in mucosa-associated tissues

21 January 2018

1 reference

Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract

21 January 2018

1 reference

Long-term maintenance of B cell immunity to influenza virus hemagglutinin in mice following DNA-based immunization

21 January 2018

1 reference

Protection from respiratory virus infections can be mediated by antigen-specific CD4(+) T cells that persist in the lungs

21 January 2018

1 reference

Cell-mediated immunity to respiratory virus infections

21 January 2018

1 reference

Heterologous protection against influenza by injection of DNA encoding a viral protein

21 January 2018

1 reference

Human clinical trials of plasmid DNA vaccines

21 January 2018

1 reference

Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine

21 January 2018

1 reference

Clinical safety and efficacy of a powdered Hepatitis B nucleic acid vaccine delivered to the epidermis by a commercial prototype device.

21 January 2018

1 reference

Hepatitis B DNA vaccine induces protective antibody responses in human non-responders to conventional vaccination.

21 January 2018

1 reference

A phase I study of immunization using particle-mediated epidermal delivery of genes for gp100 and GM-CSF into uninvolved skin of melanoma patients.

21 January 2018

1 reference

Immunological validation of the EpitOptimizer program for streamlined design of heteroclitic epitopes.

21 January 2018

1 reference

Plasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvants for DNA vaccines.

21 January 2018

1 reference

Potent protective cellular immune responses generated by a DNA vaccine encoding HSV-2 ICP27 and the E. coli heat labile enterotoxin.

21 January 2018

1 reference

Rational design of gene-based vaccines

21 January 2018

1 reference

Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice

21 January 2018

1 reference

A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates

21 January 2018

1 reference

Bystander help within a polyepitope DNA vaccine improves immune responses to influenza antigens

21 January 2018

1 reference

Immunogenicity of hybrid DNA vaccines expressing hepatitis B core particles carrying human and simian immunodeficiency virus epitopes in mice and rhesus macaques.

21 January 2018

1 reference

DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge

21 January 2018

1 reference

Modulation of DNA vaccine-elicited CD8+ T-lymphocyte epitope immunodominance hierarchies

21 January 2018

1 reference

Enhancement of DNA vaccine potency through coadministration of CIITA DNA with DNA vaccines via gene gun.

21 January 2018

1 reference

Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins

21 January 2018

1 reference

Uses of granulocyte-macrophage colony-stimulating factor in vaccine development

21 January 2018

1 reference

DNA vaccination against influenza viruses: a review with emphasis on equine and swine influenza

21 January 2018

1 reference

The use of Th1 cytokines, IL-12 and IL-23, to modulate the immune response raised to a DNA vaccine delivered by gene gun.

21 January 2018

1 reference

Immunogenicity and efficacy of DNA vaccines encoding influenza A proteins in aged mice

21 January 2018

1 reference

Plasmid expressing the influenza HA gene protects old mice from lethal challenge with influenza virus

21 January 2018

1 reference

Biological features of genetic immunization

21 January 2018

1 reference

Duration of humoral immunity to common viral and vaccine antigens

21 January 2018

1 reference

Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors.

21 January 2018

1 reference

Antibody response to influenza vaccination in the elderly: a quantitative review

21 January 2018

1 reference

Pneumococcal Vaccination and Revaccination of Older Adults

21 January 2018

1 reference

Interleukin 2, but not other common gamma chain-binding cytokines, can reverse the defect in generation of CD4 effector T cells from naive T cells of aged mice

21 January 2018

1 reference

21 January 2018

1 reference

Intrinsic versus environmental influences on T-cell responses in aging

21 January 2018

1 reference

Age-associated decrease in virus-specific CD8+ T lymphocytes during primary influenza infection

21 January 2018

1 reference

21 January 2018

CD8 T cells and aging

1 reference

T cell development and receptor diversity during aging

21 January 2018

1 reference

The many important facets of T-cell repertoire diversity

21 January 2018

1 reference

Clonal expansions and loss of receptor diversity in the naive CD8 T cell repertoire of aged mice

21 January 2018

1 reference

Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus

21 January 2018

1 reference

Long-term persistence and recall of immune responses in aged mice after mucosal immunization.

21 January 2018

1 reference

Mucosal immunity and tolerance in the elderly

21 January 2018

1 reference

Chronological ageing and photoageing of dendritic cells

21 January 2018

1 reference

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

21 January 2018

1 reference

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

21 January 2018

1 reference

Live, attenuated influenza virus (LAIV) vehicles are strong inducers of immunity toward influenza B virus

21 January 2018

1 reference

Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates

21 January 2018

1 reference

Imiquimod and resiquimod in a mouse model: adjuvants for DNA vaccination by particle-mediated immunotherapeutic delivery

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.09.82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19722894%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference